tetano
Editor, Senior Moderator
J Infect Dev Ctries
. 2023 Aug 31;17(8):1055-1062.
doi: 10.3855/jidc.17456. Could ischemia-modified albumin levels predict the severity of disease in SARS-CoV-2 infection?
Mustafa Tanrıverdi[SUP] 1 [/SUP], Nevhiz Gündoğdu[SUP] 2 [/SUP], Necla Benlier[SUP] 3 [/SUP], Mustafa Yıldırım[SUP] 4 [/SUP], Hale Çeliktürk[SUP] 5 [/SUP], Hanifi Ayhan Özkur[SUP] 6 [/SUP], Pınar Günel Karadeniz[SUP] 7 [/SUP], Gülşen Özkan Tanrıverdi[SUP] 8 [/SUP], Hülya Çiçek[SUP] 9 [/SUP]
Affiliations
Introduction: Ischemia-modified albumin (IMA) level increases in inflammatory conditions. We aimed to investigate the association between IMA levels and the severity of coronavirus disease 2019 (COVID-19) infection in adult patients.
Methodology: We grouped adult patients with COVID-19 infection: Group A - mild symptoms, but normal computed tomography (CT), Group B - mild/moderate illness, and Group C - severe or critical illness. We measured IMA levels at the time of diagnosis of COVID-19 infection.
Results: Mean age of the total number of patients (n = 90) was 54.43 (± 8.11) year, and 46.7% (n = 42) were female. IMA levels were highest in Group C and lowest in A (p < 0.001). The most important factor predicting COVID-19 disease severity was IMA. Type 2 diabetes was more frequent in Group C (n = 31) than in Group B (n = 30) (p = 0.042). Asthma was less frequent, and coronary artery disease was more frequent in Group C than in Group A (n = 29) and B (p = 0.009). Duration of hospitalization was highest in Group C (p < 0.001).
Conclusions: We analyzed a sample of patients with COVID-19 infection and found that IMA predicted severe COVID-19 disease. Disease severity grouping was based on patients' clinical and radiological features. IMA level measured when SARS-CoV-2 infection is diagnosed may be a useful marker in predicting likely disease severity or intensive care need.
Keywords: COVID-19; IMA; Ischemia-modified albumin; SARS-CoV-2; pandemic; severity.
. 2023 Aug 31;17(8):1055-1062.
doi: 10.3855/jidc.17456. Could ischemia-modified albumin levels predict the severity of disease in SARS-CoV-2 infection?
Mustafa Tanrıverdi[SUP] 1 [/SUP], Nevhiz Gündoğdu[SUP] 2 [/SUP], Necla Benlier[SUP] 3 [/SUP], Mustafa Yıldırım[SUP] 4 [/SUP], Hale Çeliktürk[SUP] 5 [/SUP], Hanifi Ayhan Özkur[SUP] 6 [/SUP], Pınar Günel Karadeniz[SUP] 7 [/SUP], Gülşen Özkan Tanrıverdi[SUP] 8 [/SUP], Hülya Çiçek[SUP] 9 [/SUP]
Affiliations
- PMID: 37699088
- DOI: 10.3855/jidc.17456
Introduction: Ischemia-modified albumin (IMA) level increases in inflammatory conditions. We aimed to investigate the association between IMA levels and the severity of coronavirus disease 2019 (COVID-19) infection in adult patients.
Methodology: We grouped adult patients with COVID-19 infection: Group A - mild symptoms, but normal computed tomography (CT), Group B - mild/moderate illness, and Group C - severe or critical illness. We measured IMA levels at the time of diagnosis of COVID-19 infection.
Results: Mean age of the total number of patients (n = 90) was 54.43 (± 8.11) year, and 46.7% (n = 42) were female. IMA levels were highest in Group C and lowest in A (p < 0.001). The most important factor predicting COVID-19 disease severity was IMA. Type 2 diabetes was more frequent in Group C (n = 31) than in Group B (n = 30) (p = 0.042). Asthma was less frequent, and coronary artery disease was more frequent in Group C than in Group A (n = 29) and B (p = 0.009). Duration of hospitalization was highest in Group C (p < 0.001).
Conclusions: We analyzed a sample of patients with COVID-19 infection and found that IMA predicted severe COVID-19 disease. Disease severity grouping was based on patients' clinical and radiological features. IMA level measured when SARS-CoV-2 infection is diagnosed may be a useful marker in predicting likely disease severity or intensive care need.
Keywords: COVID-19; IMA; Ischemia-modified albumin; SARS-CoV-2; pandemic; severity.